Colartix®
For joint care
Supporting joint function is important for maintaining comfortable movement and engaging in daily activities. Consumers look for products that contribute to good mobility. Colartix, with its unique hydrolyzed cartilage matrix, helps support joint care being supported by consumer-based science.
Joint care
Why choose Colartix?
Natural and safe
Patented*
Specific technological process developed
Reduce joint discomfort
Fast action
Traceable and backed by science
*Patent granted in China, Europe and Japan, ROW in process.
Watch our video
Flex in motion
Colartix is a natural, safe ingredient designed for joint care. This unique matrix of collagen peptides and chondroitin sulphate is ideal for use in dietary supplements.
Study
Backed by consumer science
A placebo-controlled consumer study involving over 200 participants found that a daily intake of 1 gram of Colartix reduced joint discomfort across different genders, ages, and levels of sports intensity.
Find out more about the science of ColartixKey points
Easy to use
Colartix is easy to use and versatile in different applications, whether powder blends, shots, functional gummies, tablets, hard capsules.
- Easy to mix with other ingredients
- Low daily dosage of 1 gram
- No additives or E-numbers
- Safe product
Partner with us
Cobranding opportunities
Join our co-branding program for selected customers to leverage Colartix’s brand name, marketing material, science and endorsement.
Contact usPatented
Colartix is a patented solution
The patent has been granted by the European Patent Office.
Reference: EP4465823B1, published on July 2, 2025.
The patent has been granted in Japan by the Japan Patent Office.
Reference: JP7690140B1, published on June 9, 2025.
The patent has been granted in China by the China National Intellectual Property Administration.
Reference: CN118829360, published on August 5, 2025.
Reference: EP4465823B1, published on July 2, 2025.
The patent has been granted in Japan by the Japan Patent Office.
Reference: JP7690140B1, published on June 9, 2025.
The patent has been granted in China by the China National Intellectual Property Administration.
Reference: CN118829360, published on August 5, 2025.